Skip to content

BECARV

In bankruptcy Public limited companyfounded 2011Boulevard de Patience et Beaujonc 3, 4000 LiègeKBO/BCE: BE 0840.777.885

No group

BECARV has no parent and no holdings in its annual accounts.

At the same address

Boulevard de Patience et Beaujonc 3, 4000 Liège · 47 other companies
SIEMENS INDUSTRY SOFTWARE
establishment since 01-10-2021 · founded in 1985 · group Siemens Aktiengesellschaft
487 FTE (2025)
0428.295.877
NYXOAH
establishment since 08-12-2025 · founded in 2009
43 FTE (2025)
0817.149.675
Hyloris Pharmaceuticals
registered office since 10-04-2017 · founded in 2017
turnover €3.8m (2025)
0674.494.151
EYED PHARMA
registered office since 20-12-2012 · founded in 2012
29 FTE (2025)
0508.599.605
Hyloris Developments
registered office since 05-12-2013 · founded in 2013
12 FTE (2025)
0542.737.368
KiOmed Pharma
establishment since 01-02-2024 · founded in 2012
30 FTE (2025)
0846.318.862
aptaskil
establishment since 20-09-2024 · founded in 2001
39 FTE (2025)
0476.430.049
Gevers Patents
establishment since 17-10-2022 · founded in 1993
40 FTE (2025)
0451.659.120
GEVERS LEGAL
establishment since 01-10-1998 · founded in 1997
45 FTE (2025)
0461.423.159
CEFALY Technology
registered office since 30-11-2004 · founded in 2004 · negative equity (2025)
4.1 FTE (2025)
0870.578.661
and 37 more

Earlier ties

OncoDNA
via Jean STEPHENNE, no longer at OncoDNA · Director · deed of 20-12-2019
founded in 2012 · negative equity (2025)
21 FTE (2025)
BNP Paribas Fortis
via Jean STEPHENNE, no longer at BNP Paribas Fortis · Director · deed of 24-01-2014
founded in 1934 · group BNP PARIBAS
total assets €282.82bn (2025)
GlaxoSmithKline Biologicals
via Jean STEPHENNE, no longer at GlaxoSmithKline Biologicals · Director · deed of 08-12-2011
founded in 1990
8,371 FTE (2025)
GROUPE BRUXELLES LAMBERT
via Jean STEPHENNE, no longer at GROUPE BRUXELLES LAMBERT · Director · deed of 03-06-2013
founded in 1902
total assets €13.29bn (2025)
BESIX Group
via Jean STEPHENNE, no longer at BESIX Group · Permanent representative · deed of 06-01-2006
founded in 1909
turnover €9.3m (2025)
FONDS DE LA RECHERCHE SCIENTIFIQUE-FNRS
via Jean STEPHENNE, no longer at FONDS DE LA RECHERCHE SCIENTIFIQUE-FNRS · Director · deed of 25-10-2013
founded in 2006
2,181 FTE (2025)
Show 9 more earlier ties
FONDATION CONTRE LE CANCER
via Jean STEPHENNE, no longer at FONDATION CONTRE LE CANCER · Director · deed of 05-12-2018
founded in 2005
87 FTE (2025)
MEDIAFIN
via Jean STEPHENNE, no longer at MEDIAFIN · Director
founded in 1926
300 FTE (2025)
ASEPTIC TECHNOLOGIES
via Jean STEPHENNE, no longer at ASEPTIC TECHNOLOGIES · Director · deed of 06-08-2010
founded in 2002
61 FTE (2025)
Fondation Saint - Luc
via Jean STEPHENNE, no longer at Fondation Saint - Luc · Class B director · deed of 06-05-2013
founded in 2009
5.5 FTE (2025)
SPARKOH!
via Jean STEPHENNE, no longer at SPARKOH! · Director
founded in 1997
42 FTE (2025)
NANOCYL
via Jean STEPHENNE, no longer at NANOCYL · Director · deed of 22-06-2015
founded in 2002
47 FTE (2026)
LYS MEDICAL
via Jean STEPHENNE, no longer at LYS MEDICAL · Director and chair of the board · deed of 04-11-2019
founded in 2018
total assets €1.3m (2025)
FONDS FEDERAL DE LA RECHERCHE SCIENTIFIQUE
via Jean STEPHENNE, no longer at FONDS FEDERAL DE LA RECHERCHE SCIENTIFIQUE · Director · deed of 17-02-2015
founded in 1928
ICC Belgique
via Jean STEPHENNE, no longer at ICC Belgique · Director
founded in 2007

Connections & network

5 connected companies
Linked via shared directors
n-Side
via Jean STEPHENNE · Director · deed of 29-03-2021
Founded in 2000 · 161 FTE (2025)
→
BePharBel Manufacturing
via Jean STEPHENNE · Director · deed of 11-10-2024
Founded in 2012 · 100 FTE (2025)
→
SOPARTEC
via Jean STEPHENNE · Director · deed of 27-11-2020
Founded in 1942 · 4.8 FTE (2025)
→
NOVAFORM PHARMA
via Jean STEPHENNE · Director · deed of 15-07-2026
Founded in 2026
→
Show 1 more company with a shared director
Innosté
via Jean STEPHENNE · Permanent representative · deed of 16-06-2023
No longer active · total assets €792,138 (2025)
→